AU3177500A - Proteins for diagnosis and treatment of breast cancer - Google Patents

Proteins for diagnosis and treatment of breast cancer

Info

Publication number
AU3177500A
AU3177500A AU31775/00A AU3177500A AU3177500A AU 3177500 A AU3177500 A AU 3177500A AU 31775/00 A AU31775/00 A AU 31775/00A AU 3177500 A AU3177500 A AU 3177500A AU 3177500 A AU3177500 A AU 3177500A
Authority
AU
Australia
Prior art keywords
diagnosis
proteins
treatment
breast cancer
breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31775/00A
Inventor
Bob Amess
Michael John O'hare
Rajesh Bhikhu Parekh
Robert Reid Townsend
Michael Derek Waterfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Publication of AU3177500A publication Critical patent/AU3177500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU31775/00A 1999-03-12 2000-03-13 Proteins for diagnosis and treatment of breast cancer Abandoned AU3177500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9905817 1999-03-12
GBGB9905817.4A GB9905817D0 (en) 1999-03-12 1999-03-12 Methods
PCT/GB2000/000908 WO2000055628A1 (en) 1999-03-12 2000-03-13 Proteins for diagnosis and treatment of breast cancer

Publications (1)

Publication Number Publication Date
AU3177500A true AU3177500A (en) 2000-10-04

Family

ID=10849580

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31775/00A Abandoned AU3177500A (en) 1999-03-12 2000-03-13 Proteins for diagnosis and treatment of breast cancer

Country Status (4)

Country Link
EP (1) EP1159618A1 (en)
AU (1) AU3177500A (en)
GB (1) GB9905817D0 (en)
WO (1) WO2000055628A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003507027A (en) * 1999-08-13 2003-02-25 オックスフォード グリコサイエンセス（ユーケー） リミテッド Proteins, genes and their use in the diagnosis and treatment of breast cancer
AU2001240909A1 (en) * 2000-03-20 2001-10-03 Oxford Glycosciences (Uk) Limited Proteins, genes and their use for diagnosis and treatment of breast cancer
BR0111742A (en) 2000-06-19 2004-02-03 Correlogic Systems Inc Heuristic Classification Method
EP1386275A2 (en) 2000-07-18 2004-02-04 Correlogic Systems, Inc. A process for discriminating between biological states based on hidden patterns from biological data
EP1395830B1 (en) 2001-06-15 2007-11-21 Ucb, S.A. Bcmp-101, a cancer associated protein
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
WO2004011905A2 (en) 2002-07-29 2004-02-05 Correlogic Systems, Inc. Quality assurance/quality control for electrospray ionization processes
EP1709442A4 (en) 2003-12-11 2010-01-20 Correlogic Systems Inc Method of diagnosing biological states through the use of a centralized, adaptive model, and remote sample processing
US8664358B2 (en) 2007-06-29 2014-03-04 Vermillion, Inc. Predictive markers for ovarian cancer
WO2011115225A1 (en) * 2010-03-17 2011-09-22 国立大学法人 鹿児島大学 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same
CN107614020A (en) * 2015-03-18 2018-01-19 免疫生化公司 Target the conjugate for treating cancer of intracellular tumor associated antigen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0167616B1 (en) * 1984-01-06 1995-07-26 The Regents Of The University Of California Cytokeratin tumor markers and assays for their detection
US5158893A (en) * 1986-12-11 1992-10-27 Peralta Cancer Research Institute Methods and compositions for screening carcinomas
US5188964A (en) * 1990-04-12 1993-02-23 Board Of Regents, The University Of Texas System Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
GB9423912D0 (en) * 1994-11-26 1995-01-11 Imp Cancer Res Tech Detecting tumours
AU2681997A (en) * 1996-04-26 1997-11-19 Children's Medical Center Corporation Non-invasive enzyme screen for tissue remodelling-associated conditions
US5798266A (en) * 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer

Also Published As

Publication number Publication date
GB9905817D0 (en) 1999-05-05
EP1159618A1 (en) 2001-12-05
WO2000055628A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
GB9903841D0 (en) Diagnosis and treatment of cancer
AU1967501A (en) Device and method for improved diagnosis and treatment of cancer
HUP0200763A2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
EP1007535A4 (en) Methods and compositions for diagnosis and treatment of breast cancer
AU2990695A (en) Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
ZA982968B (en) Compositions and methods for the treatment and diagnosis of breast cancer
AU2002251366A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU2001240909A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU6583700A (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
PL350890A1 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
AU3177500A (en) Proteins for diagnosis and treatment of breast cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
GB9811598D0 (en) Diagnosis and treatment of cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
PL350863A1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
ZA200108256B (en) Compositions and methods for the treatment and diagnosis of breast cancer.
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU3326000A (en) Means of early examination of malignant tumor
AU2002346049A1 (en) Coactivators in the diagnosis and treatment of breast cancer
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU3655097A (en) Brca1 compositions and methods for the diagnosis and treatment of breast cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase